title: Interaction of protein kinases A and C in their effects on the proenkephalin gene in astroglial cells.
abstract: In several cell types, the expression of the proenkephalin (PEnk) gene is enhanced after activation of protein kinase A. In the present study, astroglial cells cultured from rat cortex were used to investigate whether protein kinases A and C can act in a synergistic manner on the endogenous proenkephalin gene. The activator of protein kinase C tetradecanoylphorbolacetate (0.001-1 microM) increased the level of proenkephalin-mRNA in a concentration dependent manner. When used together with the phosphodiesterase inhibitor Rolipram (1 microM), the effect of tetradecanoylphorbolacetate (0.01 microM) was potentiated. 8-Bromoadenosine 3',5'-cyclic monophosphate (0.01-1 mM) also enhanced the expression of the proenkephalin gene. When used together with tetradecanoylphorbolacetate (0.01 and 0.1 microM), respectively, both agents had additive effects. Inhibition of protein synthesis with cycloheximide (35 microM) significantly changed the effects of both agents. While the effect of 8Br.cAMP (1 mM) on PEnk-mRNA was enhanced, that of tetradecanoylphorbolacetate (0.1 microM) was abolished. The results provide evidence for a synergistic effect of protein kinase A and C on the expression of the proenkephalin gene in astroglial cells. However, the protein kinases seem to act via different transcription factors on the expression of the proenkephalin gene.
authors: Department of Pharmacology, Freiburg University, Germany.
authors: A
authors: A
authors: Theodoridu
authors: C
authors: C
authors: Olenik
authors: C
authors: C
authors: Boeckh
authors: P
authors: P
authors: Ziefer
authors: P
authors: P
authors: Gebicke-Härter
authors: D K
authors: DK
authors: Meyer
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D002772:Cholera Toxin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology; D004357:Drug Synergism; D004745:Enkephalins / Q000235:genetics*; D004789:Enzyme Activation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D011493:Protein Kinase C / Q000378:metabolism*; D011498:Protein Precursors / Q000235:genetics*; D011760:Pyrrolidinones / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D020889:Rolipram; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D004745:Enkephalins; D011498:Protein Precursors; D011760:Pyrrolidinones; D012333:RNA, Messenger; C029992:proenkephalin; D015124:8-Bromo Cyclic Adenosine Monophosphate; D002772:Cholera Toxin; D003513:Cycloheximide; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D020889:Rolipram; D013755:Tetradecanoylphorbol Acetate